Theravance Biopharma to Participate in an Upcoming Investor Conference
Theravance Biopharma (NASDAQ: TBPH) has announced its participation in the 7th Annual Evercore HealthCONx Conference. The company will engage in a Fireside Chat on Tuesday, December 3 at 11:15 am EST, alongside hosting in-person meetings with the investment community. The event will be accessible via webcast on Theravance.com under the Investors section, with a replay available for 30 days following the presentation.
Theravance Biopharma (NASDAQ: TBPH) ha annunciato la sua partecipazione alla 7ª Conferenza Annuale Evercore HealthCONx. L'azienda parteciperà a una conversazione informale martedì 3 dicembre alle 11:15 EST e organizzerà anche incontri di persona con la comunità degli investitori. L'evento sarà accessibile tramite webcast su Theravance.com nella sezione Investitori, con una replica disponibile per 30 giorni dopo la presentazione.
Theravance Biopharma (NASDAQ: TBPH) ha anunciado su participación en la 7ª Conferencia Anual Evercore HealthCONx. La compañía participará en una charla informal el martes 3 de diciembre a las 11:15 a.m. EST, además de organizar reuniones en persona con la comunidad de inversores. El evento estará disponible a través de webcast en Theravance.com en la sección de Inversores, y se podrá acceder a una repetición durante 30 días tras la presentación.
Theravance Biopharma (NASDAQ: TBPH)는 제7회 Evercore HealthCONx 컨퍼런스에 참여한다고 발표했습니다. 회사는 12월 3일 화요일 오전 11시 15분 EST에 진행되는 파이어사이드 차트에 참여할 예정이며, 투자 커뮤니티와의 대면 회의도 주최할 것입니다. 이 이벤트는 Theravance.com의 투자자 섹션을 통해 웹캐스트로 접근할 수 있으며, 프레젠테이션 후 30일간 재생이 가능합니다.
Theravance Biopharma (NASDAQ: TBPH) a annoncé sa participation à la 7ème Conférence Annuelle Evercore HealthCONx. L'entreprise participera à une discussion informelle le mardi 3 décembre à 11h15 EST et organisera également des réunions en personne avec la communauté des investisseurs. L'événement sera accessible via webcast sur Theravance.com dans la section Investisseurs, avec un replay disponible pendant 30 jours après la présentation.
Theravance Biopharma (NASDAQ: TBPH) hat seine Teilnahme an der 7. Jahreskonferenz Evercore HealthCONx bekannt gegeben. Das Unternehmen wird am Dienstag, den 3. Dezember, um 11:15 Uhr EST an einem Fireside Chat teilnehmen und persönliche Meetings mit der Investmentgemeinschaft abhalten. Die Veranstaltung wird über ein Webcast auf Theravance.com im Bereich Investoren zugänglich sein, mit einer Wiederholung die 30 Tage nach der Präsentation verfügbar ist.
- None.
- None.
Webcast of the event may be accessed by visiting Theravance.com, under the Investors section, Events and Presentations. Replay of the webcast will be archived on the Company's website for 30 days.
About Theravance Biopharma
Theravance Biopharma, Inc.'s focus is to deliver Medicines that Make a Difference® in people's lives. In pursuit of its purpose, Theravance Biopharma leverages decades of expertise, which has led to the development of FDA-approved YUPELRI® (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Ampreloxetine, its late-stage investigational once-daily norepinephrine reuptake inhibitor in development for symptomatic neurogenic orthostatic hypotension (nOH) in patients with Multiple System Atrophy (MSA), has the potential to be a first in class therapy effective in treating a constellation of cardinal symptoms in MSA patients. The Company is committed to creating/driving shareholder value.
For more information, please visit www.theravance.com.
THERAVANCE BIOPHARMA®, THERAVANCE® and the Cross/Star logo are registered trademarks of the Theravance Biopharma group of companies (in the U.S. and certain other countries).
YUPELRI® is a registered trademark of Mylan Specialty L.P., a Viatris company. Trademarks, trade names or service marks of other companies appearing in this press release are the property of their respective owners.
Contact:
investor.relations@theravance.com
650-808-4045
View original content to download multimedia:https://www.prnewswire.com/news-releases/theravance-biopharma-to-participate-in-an-upcoming-investor-conference-302311022.html
SOURCE Theravance Biopharma, Inc.
FAQ
When is Theravance Biopharma (TBPH) presenting at the Evercore HealthCONx Conference?
How can investors access TBPH's Evercore HealthCONx Conference presentation?
How long will TBPH's Evercore Conference presentation replay be available?
What type of presentation will TBPH give at the Evercore Conference?
